Update: NeoGenomics Shares Rise After Q2 Beat

MT Newswires Live07-30

(Updates with the latest stock movement in the first paragraph and headline.)

NeoGenomics (NEO) shares were up over 15% in Wednesday trading following its better-than-expected Q2 results.

Late Tuesday, the company reported Q2 adjusted earnings of $0.05 per diluted share, up from $0.03 a year earlier.

Analysts polled by FactSet expected $0.03.

Revenue for the quarter ended June 30 was $201.7 million, up from 181.3 million a year earlier.

Analysts expected $196.9 million.

The company said it now expects 2026 revenue of $802 million to $806 million, up from its prior range of $797 million to $803 million. Analysts expect $800.4 million.

Price: 15.51, Change: +2.11, Percent Change: +15.75

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment